封面
市場調查報告書
商品編碼
2126470

擴增實境(AR)在手術規劃中的市場-策略分析與預測(2026-2031年)

Augmented Reality for Surgery Planning Market - Strategic Insights and Forecasts (2026-2031)

出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 140 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計用於手術規劃的擴增實境(AR)市場將以 12.99% 的複合年成長率成長,從 2025 年的 845,079,000 美元成長到 2031 年的 1,758,321,000 美元。

擴增實境(AR)在手術規劃領域的市場正經歷著重大變革,其驅動力包括:精準手術模式轉移、影像導引手術日益複雜化以及數位視覺化工具與手術流程的日益融合。這個市場演變的特點在於,人們逐漸認知到AR系統能夠讓外科醫生與基於CT和MRI資料集生成的3D解剖模型進行交互,從而提高術前空間感知能力,並減輕複雜手術過程中的認知負荷。先進的可視化硬體、抗蝕劑技術和手術導引平台的融合,使得手術規劃更加直覺、精準和高效。 Augmedics等公司已獲得FDA已通過核准的平台,以及美敦力(Medtronic)和Surgical Theater的整合案例,都顯示AR已從實驗性視覺化領域走向規範的臨床應用。目前,AR的應用主要集中在解剖學精確度具有顯著臨床和經濟影響的專科領域,特別是神經外科、整形外科和脊椎外科。隨著市場對軟體功能、導航整合和臨床證據產生進行大量投資,AR 在手術規劃中的應用正在成為現代數位手術生態系統的關鍵組成部分。

市場促進因素

  • 影像導引手術中手術流程的日益複雜是推動擴增實境(AR)手術規劃市場發展的主要動力。在神經外科、脊椎外科和重組手術中,準確解讀患者特定的解剖結構變得至關重要。隨著影像資料量的成長和手術的複雜性增加,對能夠減輕規劃階段認知負擔的可視化工具的需求也日益成長。 AR系統使外科醫生能夠與基於CT和MRI資料集產生的3D解剖模型進行交互,從而提高術前空間感知能力。 Augmedics和Surgical Theater等公司的臨床應用表明,供應商並未將AR定位為獨立的可視化技術,而是將其作為導航工作流程的實用擴展,從而推動了基於AR的手術規劃的持續發展。影像導引手術導航平台的成長,以及AR功能的整合,進一步加速了市場成長。醫院已在脊椎、顱腦、耳鼻喉科和整形外科手術的導航技術方面投入大量資金。 AR供應商正擴大將其軟體整合到現有的導航生態系統中,而不是取而代之。Medtronic的夥伴關係及其導航平台的開發表明,擴增實境(AR)功能正被整合到更廣泛的手術導航系統中,降低了醫療專業人員採用該技術的門檻。支持臨床應用的監管進展正在檢驗安全性和臨床性能要求,並擴大目標市場。美國食品藥物管理局(FDA)對基於AR的手術導航平台的批准,透過檢驗安全性和臨床性能要求,進一步擴大了目標市場。提高手術室效率的壓力促使醫院管理者對能夠減少工作流程中斷並提高手術確定性的技術越來越感興趣。可視化硬體和對準技術的進步正在提高AR技術在更多醫院中的經濟可行性。

市場限制因素

  • 手術工作流程中高度整合的要求通常會導致更長的部署時間和更高的部署成本。成功部署需要與影像系統、導航平台、醫院IT基礎設施和手術器械相容。由於缺乏跨多個專科的長期臨床證據,供應商若想拓展現有應用場景,引進週期將會延長。採購委員會通常要求提供特定專科的治療結果數據,才能批准購買相關技術。醫療系統的資金限制要求醫療機構在批准大規模部署前,必須證明其能帶來可衡量的改善。外科醫生在培訓和部署方面面臨的障礙可能會延遲部署,尤其是在缺乏高級影像導引手術經驗的醫療機構。虛擬解剖模型與實際解剖結構之間的不精確對齊會降低臨床可靠性,並由於精確度和對齊要求,限制其在高風險手術中的應用。

目錄

第1章執行摘要

第2章:市場概述

  • 市場概覽
  • 市場的定義
  • 分析範圍
  • 市場區隔

第3章:商業環境

  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 波特五力分析
  • 產業價值鏈分析
  • 政策與法規
  • 策略建議

第4章 技術展望

第5章 手術規劃中的擴增實境(AR)市場:依手術專科分類

  • 整形外科手術
  • 神經外科
  • 心血管外科
  • 整形外科/重組外科
  • 胃腸外科手術
  • 其他

第6章 手術規劃中的擴增實境(AR)市場:依組件分類

  • 硬體(AR眼鏡、顯示器、攝影機)
  • 軟體(手術規劃軟體、AR應用程式)
  • 服務(諮詢、支援、培訓)

第7章擴增實境(AR)在手術規劃中的市場:按應用領域分類

  • 術前計劃
  • 術中導航
  • 培訓和教育
  • 手術視野

第8章 手術規劃的擴增實境(AR)市場:依最終使用者分類

  • 醫院和診所
  • 門診手術中心
  • 研究機構
  • 醫學院
  • 其他

第9章擴增實境(AR)在手術規劃中的市場:按地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 其他
  • 中東和非洲
    • 沙烏地阿拉伯
    • UAE
    • 其他
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 印尼
    • 泰國
    • 其他

第10章:競爭環境與分析

  • 主要公司及策略分析
  • 市佔率分析
  • 企業合併、合約、商業夥伴關係
  • 競爭環境儀錶板

第11章:公司簡介

  • Medtronic Plc
  • Accuvein Inc.
  • Echopixel, Inc.
  • Philips Healthcare
  • Scopis Gmbh
  • Augmedics
  • Surgical Theater LLC
  • Intuitive Surgical, Inc.
  • Virtamed Ag
  • Vuzix Corporation

第12章附錄

簡介目錄
Product Code: KSI061615986

The Augmented Reality for Surgery Planning Market is expected to grow at a 12.99% CAGR, increasing from USD 845.079 million in 2025 to USD 1758.321 million in 2031.

The augmented reality for surgery planning market is undergoing significant transformation driven by the paradigm shift toward precision surgery, the growing complexity of image-guided procedures, and the increasing integration of digital visualization tools into surgical workflows. The market's evolution is characterized by the recognition that AR systems allow surgeons to interact with three-dimensional anatomical models derived from CT and MRI datasets, improving spatial understanding before surgery and reducing cognitive burden during complex interventions. The convergence of advanced visualization hardware, registration technology, and surgical navigation platforms is enabling more intuitive, accurate, and efficient surgical planning. FDA-cleared platforms from companies such as Augmedics and integrations involving Medtronic and Surgical Theater demonstrate that AR has progressed beyond experimental visualization into regulated clinical applications. Adoption remains concentrated in specialties where anatomical precision carries substantial clinical and economic consequences, particularly neurosurgery, orthopedic surgery, and spine procedures. The market is witnessing significant investment in software capabilities, navigation integration, and clinical evidence generation, positioning AR for surgery planning as a critical component of modern digital surgery ecosystems.

Market Drivers

  • The growing procedural complexity in image-guided surgery represents the primary driver for the AR for surgery planning market. Neurosurgical, spinal, and reconstructive procedures increasingly depend on accurate interpretation of patient-specific anatomy. Higher imaging volumes and more complex interventions have increased demand for visualization tools that reduce cognitive burden during planning. AR systems allow surgeons to interact with three-dimensional anatomical models derived from CT and MRI datasets, improving spatial understanding before surgery. Clinical deployments by Augmedics and Surgical Theater illustrate how suppliers are positioning AR as a practical extension of navigation workflows rather than a standalone visualization technology, resulting in sustained growth in AR surgery planning utilization. The expansion of image-guided surgical navigation platforms is further accelerating market growth through integration of AR capabilities. Hospitals are already investing heavily in navigation technologies for spine, cranial, ENT, and orthopedic procedures. AR vendors increasingly integrate their software into existing navigation ecosystems rather than replacing them. Medtronic's partnerships and navigation platform development demonstrate how AR capabilities are being incorporated into broader surgical guidance systems, lowering adoption barriers for healthcare providers. Regulatory progress supporting clinical adoption is expanding the addressable market by validating safety and clinical performance requirements. FDA clearances for AR-based surgical guidance platforms have expanded the addressable market by validating safety and clinical performance requirements. Pressure to improve operating room efficiency is attracting attention from hospital administrators seeking technologies that reduce workflow interruptions and improve surgical confidence. Advances in visualization hardware and registration technology are improving the economic viability of AR deployment across a broader range of hospitals.

Market Restraints

  • High integration requirements within surgical workflows frequently extend implementation timelines and increase deployment costs. Successful deployment requires compatibility with imaging systems, navigation platforms, hospital IT infrastructure, and surgical instruments. Limited long-term clinical evidence across multiple specialties creates a slower adoption cycle for vendors seeking expansion beyond established use cases. Procurement committees frequently require specialty-specific outcome data before approving technology purchases. Capital expenditure constraints in healthcare systems require providers to demonstrate measurable improvements before approving large-scale deployments. Surgeon training and adoption barriers can delay implementation, particularly in facilities with limited experience in advanced image-guided surgery. Accuracy and registration requirements can reduce clinical confidence and restrict use in high-risk procedures if alignment between virtual anatomical models and physical anatomy is not precise.

Technology and Segment Insights

  • The technology landscape is characterized by the growing importance of software capabilities, navigation integration, and ergonomic hardware design. Neurosurgery represents the most strategically important segment because procedures frequently involve complex anatomy, limited surgical access, and high clinical consequences associated with navigation errors. Surgical teams routinely analyze extensive MRI and CT datasets before intervention, creating a natural environment for immersive three-dimensional planning tools. Demand is supported by the need for improved visualization of tumors, vascular structures, neural pathways, and critical functional regions. AR systems allow surgeons to rehearse approaches, evaluate trajectories, and overlay anatomical information during planning and navigation. Medtronic's collaboration with Surgical Theater and expanding AR-enabled cranial navigation capabilities demonstrate continued investment in this specialty. Purchasing decisions in neurosurgery differ from those in many other specialties. Buyers place greater emphasis on accuracy, image fidelity, workflow integration, and compatibility with navigation systems than on hardware specifications alone. Hospitals also require robust clinical validation because neurosurgical procedures carry substantial patient safety implications. As a result, suppliers compete through software capabilities, navigation integration, and evidence generation rather than display hardware alone. The segment analysis reveals that competition is increasingly centered on ecosystem integration rather than standalone hardware performance. North America remains the most mature commercial environment, with the United States generating much of the clinical evidence, regulatory activity, and commercialization activity associated with AR surgical navigation. European adoption is driven primarily by university hospitals, research collaborations, and advanced surgical centers. Asia Pacific presents long-term growth potential because of expanding healthcare infrastructure, increasing surgical volumes, and rising investment in digital operating room technologies. The integration of navigation platforms is becoming increasingly important as AR vendors integrate their software into existing navigation ecosystems rather than replacing them.

Competitive and Strategic Outlook

  • The competitive landscape remains technology-led and increasingly centered on integration within surgical navigation ecosystems, including established medical technology companies alongside specialized AR developers. Medtronic leverages its installed base of navigation and imaging systems, enabling AR functionality to be incorporated into existing surgical workflows, with partnerships and platform strategy strengthening switching costs and creating opportunities for broader adoption across multiple specialties. Augmedics has focused on dedicated AR navigation systems, particularly within spine surgery, with commercial progress, clinical utilization, and continued product development highlighting the role of specialist vendors in advancing AR adoption. Philips Healthcare benefits from its presence in imaging and image-guided therapy infrastructure, while Intuitive Surgical contributes expertise in digital surgical workflows and visualization environments. Companies such as Surgical Theater, EchoPixel, Scopis GmbH, Vuzix Corporation, AccuVein, and VirtaMed AG address specific visualization, simulation, guidance, and hardware requirements, with competitive positioning often depending on workflow specialization, imaging compatibility, and clinical validation. Barriers to entry remain substantial, with regulatory approval requirements, clinical evidence generation, surgeon adoption cycles, and integration demands creating challenges for new entrants lacking established healthcare relationships. Recent key developments include SKIA securing FDA 510(k) clearance for its SKIA HEAD platform, a tablet-based augmented reality system that projects patient-specific 3D anatomy onto the body. Pixee Medical received FDA clearance for Knee+ NexSight, a next-generation augmented reality solution for total knee arthroplasty. VB Spine agreed to acquire Augmedics' xvision Spine System, adding FDA-cleared augmented reality navigation capabilities for real-time anatomical visualization and planning support. OnPoint AI highlighted its OnPoint AR Spine System, which overlays virtual surgical guides and implants directly into the surgeon's field of view. Medivis received FDA clearance for its Cranial Navigation platform, becoming the first augmented reality system authorized for intraoperative cranial neurosurgery guidance.

Short Conclusion

  • The augmented reality for surgery planning market is positioned for sustained growth driven by the convergence of procedural complexity, navigation platform integration, and technological advancement. The transition from experimental visualization toward integrated surgical planning ecosystems represents a fundamental shift in digital surgery. While challenges related to workflow integration, clinical evidence, and adoption barriers persist, strategic investments in software capabilities, navigation integration, and regulatory clearance are creating durable competitive advantages for market leaders. The long-term market outlook remains positive, with AR for surgery planning evolving into a critical component of modern digital surgery, supporting improved planning accuracy, workflow efficiency, and clinical outcomes across neurosurgery, orthopedics, and emerging surgical specialties.

Key Benefits of this Report

  • Insightful Analysis: Detailed market insights across regions, customer segments, policies, socio-economic factors, consumer preferences, and industry verticals.
  • Competitive Landscape: Understand strategic moves by key players to identify optimal market entry approaches.
  • Market Drivers and Future Trends: Assess major growth forces and emerging developments shaping the market.
  • Actionable Recommendations: Support strategic decisions to unlock new revenue streams.
  • Caters to a Wide Audience: Suitable for startups, research institutions, consultants, SMEs, and large enterprises.

What Businesses Use Our Reports For

  • Industry and market insights, opportunity assessment, product demand forecasting, market entry strategy, geographical expansion, capital investment decisions, regulatory analysis, new product development, and competitive intelligence.

Report Coverage

  • Historical data from 2021 to 2024, Base year 2025, and Forecast years from 2026 to 2031
  • Growth opportunities, challenges, supply chain outlook, regulatory framework, and trend analysis
  • Competitive positioning, strategies, and market share evaluation, and trade analysis
  • Revenue growth and forecast assessment across segments and regions
  • Company profiling including strategies, products, financials, and key developments

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. AUGMENTED REALITY FOR SURGERY PLANNING MARKET BY SURGICAL SPECIALTY

  • 5.1. Introduction
  • 5.2. Orthopedic Surgery
  • 5.3. Neurosurgery
  • 5.4. Cardiovascular Surgery
  • 5.5. Plastic And Reconstructive Surgery
  • 5.6. Gastrointestinal Surgery
  • 5.7. Others

6. AUGMENTED REALITY FOR SURGERY PLANNING MARKET BY COMPONENT

  • 6.1. Introduction
  • 6.2. Hardware (AR Glasses, Displays, Cameras)
  • 6.3. Software (Surgical Planning Software, Ar Apps)
  • 6.4. Services (Consulting, Support, Training)

7. AUGMENTED REALITY FOR SURGERY PLANNING MARKET BY APPLICATION

  • 7.1. Introduction
  • 7.2. Preoperative Planning
  • 7.3. Intraoperative Navigation
  • 7.4. Training And Education
  • 7.5. Surgical Visualization

8. AUGMENTED REALITY FOR SURGERY PLANNING MARKET BY END-USER

  • 8.1. Introduction
  • 8.2. Hospitals And Clinics
  • 8.3. Ambulatory Surgery Centers
  • 8.4. Research Institutions
  • 8.5. Medical Schools
  • 8.6. Others

9. AUGMENTED REALITY FOR SURGERY PLANNING MARKET BY GEOGRAPHY

  • 9.1. Introduction
  • 9.2. North America
    • 9.2.1. USA
    • 9.2.2. Canada
    • 9.2.3. Mexico
  • 9.3. South America
    • 9.3.1. Brazil
    • 9.3.2. Argentina
    • 9.3.3. Others
  • 9.4. Europe
    • 9.4.1. Germany
    • 9.4.2. France
    • 9.4.3. United Kingdom
    • 9.4.4. Spain
    • 9.4.5. Others
  • 9.5. Middle East and Africa
    • 9.5.1. Saudi Arabia
    • 9.5.2. UAE
    • 9.5.3. Others
  • 9.6. Asia Pacific
    • 9.6.1. China
    • 9.6.2. India
    • 9.6.3. Japan
    • 9.6.4. South Korea
    • 9.6.5. Indonesia
    • 9.6.6. Thailand
    • 9.6.7. Others

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 10.1. Major Players and Strategy Analysis
  • 10.2. Market Share Analysis
  • 10.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 10.4. Competitive Dashboard

11. COMPANY PROFILES

  • 11.1. Medtronic Plc
  • 11.2. Accuvein Inc.
  • 11.3. Echopixel, Inc.
  • 11.4. Philips Healthcare
  • 11.5. Scopis Gmbh
  • 11.6. Augmedics
  • 11.7. Surgical Theater LLC
  • 11.8. Intuitive Surgical, Inc.
  • 11.9. Virtamed Ag
  • 11.10. Vuzix Corporation

12. APPENDIX

  • 12.1. Currency
  • 12.2. Assumptions
  • 12.3. Base and Forecast Years Timeline
  • 12.4. Key benefits for the stakeholders
  • 12.5. Research Methodology
  • 12.6. Abbreviations